Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

UK BROKER RATINGS SUMMARY: HSBC Cuts Shell Buts Raises Next

Fri, 01st May 2020 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday afternoon:

----------

FTSE 100

----------

HSBC CUTS SHELL TO 'HOLD' (BUY)

----------

GOLDMAN SACHS CUTS SHELL B PRICE TARGET TO 1850 (2000) PENCE - 'BUY'

----------

BERENBERG CUTS SHELL B TO 'HOLD' (BUY) - PRICE TARGET 1440 (1450) PENCE

----------

HSBC RAISES NEXT TO 'BUY' ('HOLD') - TARGET 5570 (7050) PENCE

----------

UBS RAISES WHITBREAD TO 'BUY' ('NEUTRAL') - TARGET 3610 (4875) PENCE

----------

LIBERUM CUTS HARGREAVES LANSDOWN TO 'HOLD' ('BUY') - TARGET 1540 (2075) PENCE

----------

BARCLAYS RAISES ST JAMES'S PLACE TARGET TO 1118 (1098) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 9200 (9000) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES RECKITT BENCKISER PRICE TARGET TO 5900 (5860) PENCE - 'HOLD'

----------

BARCLAYS RAISES RECKITT BENCKISER PRICE TARGET TO 7900 (6900) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES RECKITT BENCKISER PRICE TARGET TO 7450 (7350) PENCE - 'BUY'

----------

HSBC RAISES RECKITT BENCKISER PRICE TARGET TO 7300 (7000) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES FERGUSON PRICE TARGET TO 6600 (5900) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BAE SYSTEMS PRICE TARGET TO 695 (730) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS SHELL PRICE TARGET TO 1700 (1900) PENCE - 'OUTPERFORM'

----------

UBS CUTS INTERCONTINENTAL HOTELS PRICE TARGET TO 3900 (4150) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES BARCLAYS PRICE TARGET TO 160 (150) PENCE - 'BUY'

----------

JPMORGAN RAISES ASTRAZENECA PRICE TARGET TO 9500 (8500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS MELROSE INDUSTRIES PRICE TARGET TO 165 (180) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES SHELL PRICE TARGET TO 1150 (1140) PENCE - 'HOLD'

----------

RBC RAISES SHELL B PRICE TARGET TO 1800 (1700) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS RAISES RECKITT BENCKISER PRICE TARGET TO 6300 (5950) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS CUTS INTERNATIONAL CONSOLIDATED AIRLINES TO 'NEUTRAL' (BUY) - PRICE TARGET 250 (500) PENCE

----------

CREDIT SUISSE RAISES RECKITT BENCKISER PRICE TARGET TO 6100 (5900) PENCE - 'NEUTRAL'

----------

DZ BANK RAISES FAIR VALUE FOR RECKITT BENCKISER TO 7100 (6500) PENCE - 'BUY'

----------

DZ BANK RAISES FAIR VALUE FOR GLAXOSMITHKLINE TO 1950 (1900) PENCE - 'BUY'

----------

RBC RAISES RECKITT BENCKISER PRICE TARGET TO 4900 (4600) PENCE - 'UNDERPERFORM'

----------

DZ BANK RAISES FAIR VALUE FOR ASTRAZENECA TO 7300 (6500) PENCE - 'SELL'

----------

RBC CUTS RSA INSURANCE PRICE TARGET TO 550 (600) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES ASHTEAD GROUP TARGET TO 2500 (2050) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

BARCLAYS CUTS JOHN LAING PRICE TARGET TO 425 (440) PENCE - 'EQUAL WEIGHT'

----------

LIBERUM CUTS RATHBONE BROTHERS PRICE TARGET TO 1520 (2100) PENCE - 'HOLD'

----------

LIBERUM RAISES INTEGRAFIN PRICE TARGET TO 455 (435) PENCE - 'HOLD'

----------

LIBERUM CUTS QUILTER PRICE TARGET TO 145 (185) PENCE - 'BUY'

----------

LIBERUM CUTS BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 330 (384) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS IMI PRICE TARGET TO 800 (950) PENCE - 'UNDERPERFORM'

----------

JPMORGAN RAISES CONVATEC PRICE TARGET TO 167 (160) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 380 (400) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES SYNTHOMER PRICE TARGET TO 330 (260) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES CONVATEC PRICE TARGET TO 180 (175) PENCE - 'UNDERPERFORM'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG INITIATES AB DYNAMICS WITH 'BUY' - TARGET 2050 PENCE

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.